We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-5.34%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.27B
AUM Growth
-$1.89B
Cap. Flow
-$1.48B
Cap. Flow %
-45.31%
Top 10 Hldgs %
36.77%
Holding
111
New
16
Increased
19
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$98.2M
2
V icon
Visa
V
+$94.7M
3
LVS icon
Las Vegas Sands
LVS
+$94.4M
4
SCHW
Charles Schwab
SCHW
+$86.5M
5
SPGI icon
S&P Global
SPGI
+$84.2M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$222M
2
AMZN icon
Amazon
AMZN
+$194M
3
ADI icon
Analog Devices
ADI
+$144M
4
PWR icon
Quanta Services
PWR
+$133M
5
COR icon
Cencora
COR
+$122M

Sector Composition

Rank Sector Weight
1 Healthcare 47.04%
2 Consumer Discretionary 18.58%
3 Financials 10.68%
4 Industrials 10.44%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTC icon
76
Benitec Biopharma
BNTC
$468M
$1.8M 0.05%
45,235
– –
IMRX icon
77
Immuneering
IMRX
$292M
$1.29M 0.04%
200,000
– –
CANO.WS
78
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$1.06M 0.03%
674,066
-500
-0.1% -$720
TRDA icon
79
Entrada Therapeutics
TRDA
$267M
$995K 0.03%
106,000
– –
EUCR
80
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$984K 0.03%
99,999
– –
FLAC
81
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$860K 0.03%
87,498
– –
DBTX
82
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$801K 0.02%
263,600
– –
MGTX icon
83
MeiraGTx Holdings
MGTX
$1.21B
$479K 0.01%
34,600
– –
TMPMW
84
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$22K ﹤0.01%
66,666
– –
EBACW
85
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$20K ﹤0.01%
100,000
– –
FLACW
86
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$7K ﹤0.01%
29,166
– –
EUCRW
87
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$6K ﹤0.01%
33,333
– –
ABCL icon
88
CALL
AbCellera Biologics
ABCL
$2.12B
– –
-367,100
Closed -$5.25M
ADBE icon
89
Adobe
ADBE
$105B
– –
-392,207
Closed -$222M
ADI icon
90
Analog Devices
ADI
$190B
– –
-819,310
Closed -$144M
ALIT icon
91
Alight
ALIT
$407M
– –
-390,500
Closed -$84.4M
ALLO icon
92
Allogene Therapeutics
ALLO
$694M
– –
-265,116
Closed -$3.96M
CHRS icon
93
Coherus Oncology
CHRS
$196M
– –
-1,218,792
Closed -$19.5M
CPRT icon
94
Copart
CPRT
$27.5B
– –
-1,220,000
Closed -$46.2M
CVNA icon
95
Carvana
CVNA
$77.9B
– –
-2,139,035
Closed -$99.2M
ETSY icon
96
Etsy
ETSY
$7.85B
– –
-122,158
Closed -$26.7M
GRAB icon
97
Grab
GRAB
$14.9B
– –
-2,000,000
Closed -$14.3M
KBR icon
98
KBR
KBR
$4.8B
– –
-685,500
Closed -$32.6M
MIST icon
99
Milestone Pharmaceuticals
MIST
$152M
– –
-851,291
Closed -$5.58M
MNST icon
100
Monster Beverage
MNST
$88.5B
– –
-2,287,400
Closed -$110M
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Suvretta Capital Management held 111 positions worth $3.27B, down 37% from $5.16B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Suvretta Capital Management withdrew a net $1.48B in Q1 2022, closing 24 positions and reducing 19 holdings. Its most notable exit was Adobe, an estimated $222M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Suvretta Capital Management opened a new position in Centene worth $101M.

  • Suvretta Capital Management's largest Q1 2022 buy was Centene: 1,197,206 shares worth $101M.
  • Suvretta Capital Management added most to Marqeta in Q1 2022, an estimated $30M increase.
  • Suvretta Capital Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $194M.
  • Suvretta Capital Management fully exited Adobe in Q1 2022, selling an estimated $222M.
  • Suvretta Capital Management's ten largest holdings make up 37% of its $3.27B portfolio in Q1 2022.
  • Suvretta Capital Management opened 16 new positions and closed 24 in Q1 2022.
  • Suvretta Capital Management's portfolio value fell 37% quarter-over-quarter to $3.27B.

Based on Suvretta Capital Management's 13F filing for Q1 2022, filed 16 May 2022.